Previous Article | Next Article ![]()
Mol Cell Biol, April 1998, p. 1946-1955, Vol. 18, No. 4
Program in Biological and Biomedical
Sciences1 and
Department of
Neurobiology,2 Harvard Medical School, and
Division of Neuroscience, Department of Neurology,
Children's Hospital,3 Boston, Massachusetts
02115
Received 25 August 1997/Returned for modification 24 October
1997/Accepted 23 December 1997
The mechanisms by which growth factor-induced signals are
propagated to the nucleus, leading to the activation of the
transcription factor CREB, have been characterized. Nerve growth factor
(NGF) was found to activate multiple signaling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133 (Ser-133). NGF activates the extracellular signal-regulated kinase
(ERK) mitogen-activated protein kinases (MAPKs), which in turn
activate the pp90 ribosomal S6 kinase (RSK) family of Ser/Thr kinases,
all three members of which were found to catalyze CREB Ser-133
phosphorylation in vitro and in vivo. In addition to the ERK/RSK
pathway, we found that NGF activated the p38 MAPK and its
downstream effector, MAPK-activated protein kinase 2 (MAPKAP kinase 2), resulting in phosphorylation of CREB at Ser-133. Inhibition of either the ERK/RSK or the p38/MAPKAP kinase 2 pathway only partially blocked NGF-induced CREB Ser-133 phosphorylation, suggesting that either pathway alone is sufficient for coupling the NGF signal to
CREB activation. However, inhibition of both the ERK/RSK and the
p38/MAPKAP kinase 2 pathways completely abolished NGF-induced CREB
Ser-133 phosphorylation. These findings indicate that NGF activates two
distinct MAPK pathways, both of which contribute to the
phosphorylation of the transcription factor CREB and the activation of
immediate-early genes.
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Nerve Growth Factor Activates Extracellular Signal-Regulated
Kinase and p38 Mitogen-Activated Protein Kinase Pathways To
Stimulate CREB Serine 133 Phosphorylation

*
Corresponding author. Mailing address: Division of
Neuroscience, Department of Neurology, John F. Enders Pediatric
Research Laboratories, Children's Hospital, 300 Longwood Ave., Boston, MA 02115. Phone: (617) 355-8344. Fax: (617) 738-1542. E-mail: greenberg{at}a1.tch.harvard.edu.
Present address: Molecular Toxicology Program, Department of
Environmental Health, University of Washington, Seattle, WA 98195.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|